The Bland Company, a food technology startup based in London, has successfully closed a $2.7M pre-seed funding round. The investment was led by Initialized Capital, with additional participation from Entrepreneurs First, Alumni Ventures, Transpose Platform, and Behind Genius Ventures. The capital will be used to scale a proprietary platform that converts agricultural byproducts into functional plant proteins, initially targeting the global egg shortage.
Addressing Supply Chain Volatility
The commercial egg market has faced significant instability due to recurring outbreaks of avian flu and Newcastle disease, leading to price spikes in the US and Europe. Micol Hafez, co-founder of The Bland Company, noted that market volatility has become the norm, creating a need for reliable and cost-effective alternatives that perform consistently.
The startup’s technology focuses on “feedstock-agnostic” processing. This allows the company to utilize abundant and often overlooked agricultural waste, such as rice bran, and isolate target proteins. These proteins are then restructured to mimic the functional properties of animal proteins, specifically the foaming, binding, and emulsifying capabilities of egg whites.
AI-Driven and Capital-Light Model
Unlike many competitors in the alternative protein space, The Bland Company does not rely on fermentation or expensive bioreactors. Zoe Perret, a partner at Initialized Capital, described the process as “capital-light by design,” noting its ability to integrate into existing food manufacturing infrastructure.
The company utilizes artificial intelligence to analyze how different raw materials respond to biochemical processing. This data allows them to predict functional outcomes and optimize production parameters. Perret emphasized that eggs represent an ideal entry point for the platform due to the acute supply issues and the lack of adequate existing solutions.
Yash Khandelwal, the startup’s co-founder, explained that while plants are abundant, their native proteins often lack the functionality of animal-derived counterparts. The company’s goal is to bridge this gap, creating a “biorefinery” model where a single feedstock input can yield multiple high-performance ingredients for various food and non-food applications.
